国家: 英国
语言: 英文
来源: MHRA (Medicines & Healthcare Products Regulatory Agency)
Levonorgestrel
Bayer Plc
G03AC03
Levonorgestrel
13.5mg
Intrauterine device
Intrauterine
No Controlled Drug Status
Valid as a prescribable product
BNF: 07030203; GTIN: 5010605180507
v009_0 Page 1 of 13 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack. Please compare the 'Leaflet prepared/revised date' towards the end of the leaflet to establish if there have been any changes. _If you have any doubts or queries about your medication, please contact _ _your doctor or pharmacist. _ _ _ _ _ PACKAGE LEAFLET: INFORMATION FOR THE USER JAYDESS 13.5 MG INTRAUTERINE DELIVERY SYSTEM levonorgestrel Patient’s name: <….> Doctor’s name: <….> Doctor’s phone number: <….> Date of insertion: <….> Date of removal: <….> First check-up visit: <….> Next visits: 1. <….> 2. <….> 3. <….> _ _ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects, you may get. See the end of section 4 for how to report side effects. _ _ READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. - If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. WHAT IS IN THIS LEAFLET: 1. What Jaydess is and what it is used for 2. What you need to know before you use Jaydess 3. How to use Jaydess 4. Possible side effects 5. How to store Jaydess 6. Contents of the pack and other information v009_0 Page 2 of 13 1. WHAT JAYDESS IS AND WHAT IT IS USED FOR Jaydess is used for the prevention of pregnancy (contraception) for up to three years. Jaydess is a T-shaped intrauterine delivery system (IUS) which after placement inside the womb slowly releases a small amount of the hormone levonorgestrel. Jaydess works by reducing the monthly growth of the lining of the womb and thickening the cervical mucus. These actions preve 阅读完整的文件
OBJECT 1 JAYDESS 13.5 MG INTRAUTERINE DELIVERY SYSTEM Summary of Product Characteristics Updated 25-Sep-2017 | Bayer plc This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. 1. Name of the medicinal product Jaydess 13.5 mg intrauterine delivery system. 2. Qualitative and quantitative composition The intrauterine delivery system contains 13.5 mg levonorgestrel. For the full list of excipients, see section 6.1. For details of release rates, see section 5.2. 3. Pharmaceutical form Intrauterine delivery system (IUS). The product consists of a whitish or pale yellow drug core covered with a semi-opaque membrane, which is mounted on the vertical stem of a T-body. In addition, the vertical stem contains a silver ring located close to the horizontal arms. The white T-body has a loop at one end of the vertical stem and two horizontal arms at the other end. Brown coloured removal threads are attached to the loop. The vertical stem of the IUS is loaded in the insertion tube at the tip of the inserter. The IUS and inserter are essentially free of visible impurities. Dimensions of Jaydess: 28 x 30 x 1.55 mm 4. Clinical particulars 4.1 Therapeutic indications Contraception for up to 3 years. 4.2 Posology and method of administration Posology Jaydess is inserted into the uterine cavity and is effective for up to three years. _Insertion and removal/ replacement_ It is recommended that Jaydess should only be inserted by physicians/ healthcare providers who are experienced in IUS insertions and/ or have undergone training on the Jaydess insertion procedure. Jaydess is to be inserted into the uterine cavity within seven days of the onset of menstruation. Jaydess can be replaced by a new system at any time in the cycle. Jaydess can also be inserted immediately after first trimester abortion. Postpartum insertions should be postponed u 阅读完整的文件